You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

04-148

Showing 1 - 25 of 1,968
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;

Recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • Irvine, California
  • +10 more
Nov 4, 2021

Oral Carcinoma Trial in Beijing (68Ga-FAPI-04)

Recruiting
  • Oral Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Oct 26, 2022

Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

Recruiting
  • Autoimmunity, Inflammation
  • Secukinumab s.c. injection
  • Fullerton, California
  • +93 more
Jul 14, 2022

Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

Completed
Has Results
  • Moderate to Severe Atopic Dermatitis
  • ISB 830 - Part 1 Group 1
  • +5 more
  • Birmingham, Alabama
  • +82 more
Jul 26, 2022

HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

Active, not recruiting
Has Results
  • HIV Infections
  • DTG 50 mg
  • +2 more
  • Bakersfield, California
  • +61 more
Dec 3, 2021

HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

Active, not recruiting
Has Results
  • HIV Infections
  • DTG 50 mg
  • +2 more
  • Long Beach, California
  • +64 more
Dec 3, 2021

Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

Recruiting
  • Rectal Cancer
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 11, 2023

Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

Recruiting
  • Tumor, Solid
  • Radiation: 18F-AlF-FAPi-04
  • Radiation: 18F-FDG
  • Nanchong, Sichuan, China
    Affiliated Hospital of North Sichuan Medical College
Nov 6, 2023

Necrotic Pulp Trial (Root canal instrumentation EdgeFile X7 to size #35/0.06, Root canal instrumentation EdgeFile X7 to size

Not yet recruiting
  • Necrotic Pulp
  • Root canal instrumentation EdgeFile X7 to size #35/0.06
  • +3 more
  • (no location specified)
Nov 16, 2022

Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)

Recruiting
  • Papulopustular Rosacea
  • Lotilaner Gel, 2.0%
  • Vehicle control gel
  • Oakville, Ontario, Canada
  • +4 more
Apr 20, 2023

18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

Completed
  • 18F-FAPI
  • +4 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
May 31, 2023

Non-radiographic Spondyloarthritis Trial in Worldwide (Secukinumab, Placebo)

Completed
Has Results
  • Non-radiographic Spondyloarthritis
  • Birmingham, Alabama
  • +138 more
Apr 4, 2022

COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

Not yet recruiting
  • COVID-19
  • mRNA-CR-04 vaccine 10μg
  • +3 more
  • San Diego, California
  • +3 more
Aug 1, 2023

Low Back Pain, Sciatica Trial in Petach Tikva (BOL-DP-o-04 + SCO, Placebo + SCO)

Completed
  • Low Back Pain
  • Sciatica
  • BOL-DP-o-04 + SCO
  • Placebo + SCO
  • Petach Tikva, Israel
    Beilinson Medical Center
Dec 7, 2022

Delving Into Borderline Personality Disorder Clinical Trial

Not yet recruiting
  • Borderline Personality Disorder
    • San Francisco, California
      Power Life Sciences
    Aug 4, 2023

    Myocardial Fibrosis Trial in Nanjing (68Ga/18F-FAPI-04)

    Recruiting
    • Myocardial Fibrosis
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    May 11, 2023

    HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

    Recruiting
    • HER2-positive Breast Cancer
    • +17 more
    • ALX148
    • Fam-Trastuzumab Deruxtecan-Nxki
    • Chicago, Illinois
    • +1 more
    May 19, 2023

    Pain, Osteo Arthritis Knee, Knee Osteoarthritis Trial in Worldwide (LEVI-04, Placebo:)

    Recruiting
    • Pain
    • +6 more
    • Brno, Czechia
    • +12 more
    Nov 9, 2022

    Gastric Cancer Trial in Shanghai (68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT)

    Recruiting
    • Gastric Cancer
    • 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT
    • Shanghai, Shanghai, China
      Shanghai Ruijin Hospital
    Dec 2, 2022

    Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)

    Not yet recruiting
    • Lupus Nephritis
    • Chronic Kidney Diseases
    • Dapagliflozin 10mg Tab
    • Standard maintenance therapy
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 24, 2023

    HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

    Completed
    Has Results
    • HIV Infections
    • DTG + 3TC
    • TAF based regimen (TBR)
    • Phoenix, Arizona
    • +132 more
    Jun 27, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil

    Active, not recruiting
    Has Results
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Dolutegravir (DTG)
    • +2 more
    • Phoenix, Arizona
    • +89 more
    Jun 27, 2022

    Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • GA Depot 40mg once monthly
    • GA Depot 25mg once monthly
    • Haifa, Israel
    • +6 more
    Oct 30, 2022

    Diabetic Ketoacidosis Trial in St Leonards, Redcliffe (Plasma-Lyte 148, 0.9% sodium chloride)

    Not yet recruiting
    • Diabetic Ketoacidosis
    • Plasma-Lyte 148
    • 0.9% sodium chloride
    • St Leonards, New South Wales, Australia
    • +1 more
    Feb 28, 2023

    Rectal Cancer Stage III Trial in Germany (Oxaliplatin, 85 mg/m2, 5FU; 2400 mg/m2, 5FU, 250 mg/m2)

    Recruiting
    • Rectal Cancer Stage III
    • Oxaliplatin, 85 mg/m2
    • +11 more
    • Esslingen, Baden-Wuerttemberg, Germany
    • +75 more
    Dec 13, 2022